Table 4 Qualified antibody staining panel.

From: Qualification of a multiplexed tissue imaging assay and detection of novel patterns of HER2 heterogeneity in breast cancer

Cycle #

   

Background

DAPI_1

  

FITC_1

A488

Background

Cy3_1

A555

Background

Cy5_1

A647

Background

2

DAPI_2

  

FITC_2

HER2 (TF-MA5-14509)

Thermo (Rabbit)

Cy3_2

53BP1 (Bethy A303-906A)

Bethyl (Goat)

Cy5_2

p53 (Dako_M7001)

DAKO (DO-7 IgG2b)

3

DAPI_3

  

FITC_3

PR-488 (ab199244)

Abcam

Cy3_3

ER-PE (CS74244)

CST

Cy5_3

PR-647 (ab199455)

Abcam

4

DAPI_4

  

FITC_4

Ki67-488 (CS11882)

CST

Cy3_4

HER2-PE (CS98710)

CST

Cy5_4

AR-647 (AB194195)

Abcam

5

DAPI_5

  

FITC_5

CD45-488 (FAB1430G)

R&D (2D1 clone)

Cy3_5

CK-570 (EB41-9003-82)

Ebio

Cy5_5

p53-647 (ab224942)

Abcam

6

DAPI_6

  

FITC_6

p53-FITC (Bio645803)

Biolegend (DO-7)

Cy3_6

PD-L1-555 (AB206616)

Abcam

Cy5_6

HER2-647 (ab225510)

Abcam

7

DAPI_7

  

FITC_7

CD68-488(CST24850)

CST

Cy3_7

pRb-555(CST8957)

CST

Cy5_7

PD-L1-647(CST15005)

CST